Research HighlightsResearch

Neurology Update: Dementia and cognitive disorders

February 18, 2021

Longitudinal neuroimaging biomarkers differacross Alzheimer’s disease phenotypes

Sintini et al investigated whether baseline and longitudinal patterns of tau-PET uptake and MRI grey matter volume loss mirror clinical phenotype in Alzheimer’s disease.

Read more here.

You may also like

Neurological infection with SARS-CoV-2 – the story so far

February 3, 2021

Neurology Update: Palliative care

July 6, 2021

The Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia Project

April 13, 2022

Driving with an intracranial tumor

July 13, 2020

Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description

July 27, 2020

European Journal of Neurology – Contributions from Slovakian authors

April 10, 2018

Neurology Update: Rare Diseases

March 8, 2021

Neurology Update: Palliative Care

September 10, 2019

Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis

March 3, 2021

European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the covid-19 era

April 29, 2020

Leave a Comment